Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study

Michael Crump; Stephen Couban; Ralph Meyer; Leona Rudinskas; Brent Zanke; Stefan Gluck; Andrew Maksymiuk; Paul Hoskins; Sarah Matthews; Elizabeth Eisenhauer

doi:10.1080/1042819021000002901

Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study

Michael Crump, Stephen Couban, Ralph Meyer, Leona Rudinskas, Brent Zanke, Stefan Gluck, Andrew Maksymiuk, Paul Hoskins, Sarah Matthews, Elizabeth Eisenhauer

科研成果: 期刊稿件 › 文章 › 同行评审

16 引用（Scopus）

源语言	英语
页（从-至）	1581-1587
页数	7
期刊	Leukemia and Lymphoma
卷	43
期	8
DOI	https://doi.org/10.1080/1042819021000002901
出版状态	已出版 - 2002
已对外发布	是

!!!ASJC Scopus Subject Areas

血液学
肿瘤学
癌症研究

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1080/1042819021000002901

其它文件与链接

引用此

Crump, M., Couban, S., Meyer, R., Rudinskas, L., Zanke, B., Gluck, S., Maksymiuk, A., Hoskins, P., Matthews, S., & Eisenhauer, E. (2002). Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study. Leukemia and Lymphoma, 43(8), 1581-1587. https://doi.org/10.1080/1042819021000002901

Crump, M, Couban, S, Meyer, R, Rudinskas, L, Zanke, B, Gluck, S, Maksymiuk, A, Hoskins, P, Matthews, S & Eisenhauer, E 2002, 'Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study', Leukemia and Lymphoma, 卷 43, 号码 8, 页码 1581-1587. https://doi.org/10.1080/1042819021000002901

@article{61c33622061f47d3a175204fb210718d,

title = "Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study",

author = "Michael Crump and Stephen Couban and Ralph Meyer and Leona Rudinskas and Brent Zanke and Stefan Gluck and Andrew Maksymiuk and Paul Hoskins and Sarah Matthews and Elizabeth Eisenhauer",

year = "2002",

doi = "10.1080/1042819021000002901",

language = "English",

volume = "43",

pages = "1581--1587",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "8",

}

TY - JOUR

T1 - Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma

T2 - A National Cancer Institute of Canada Clinical Trials Group Study

AU - Crump, Michael

AU - Couban, Stephen

AU - Meyer, Ralph

AU - Rudinskas, Leona

AU - Zanke, Brent

AU - Gluck, Stefan

AU - Maksymiuk, Andrew

AU - Hoskins, Paul

AU - Matthews, Sarah

AU - Eisenhauer, Elizabeth

PY - 2002

Y1 - 2002

UR - http://www.scopus.com/inward/record.url?scp=0036020961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036020961&partnerID=8YFLogxK

U2 - 10.1080/1042819021000002901

DO - 10.1080/1042819021000002901

M3 - Article

C2 - 12400600

AN - SCOPUS:0036020961

SN - 1042-8194

VL - 43

SP - 1581

EP - 1587

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 8

ER -

Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此